Skip to main content
Amneal
  • Login
  • Investors
    • Investors
    • Financial Reports
      • SEC Filings
      • Annual Reports
      • Quarterly & Other Reports
    • Events & Presentations
    • Stock Information
    • Corporate Governance
      • Policies
      • Executive Officers & Directors
      • Board Committees
    • Investor Resources
      • Analysts
      • Investor FAQ
      • Email Alerts
      • Information Request
      • RSS Feeds
  • Careers
  • News
  • Contact
Search...
  • Corporate (opens in a new tab)
  • India (opens in a new tab)
Skip to main content
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
Amneal
  • USA Flag Corporate
  • India Flag India
  • About Us
        • Overview
        • Leadership
        • Global Presence
          • Overview
          • United States
          • India
          • Ireland
        • Responsibility
        • A founder-led culture of redefining what's possible

  • Innovating Access
        • Overview
        • Timeline
        • Pipeline
        • Support
        • Driven by a passion to help more and more people be healthy

  • Essential Medicines
        • Overview
        • Biosciences
        • Specialty
        • Generics
        • Drug Safety
        • Quality
        • Product Catalog
        • Addressing increasingly complex health and systemic needs

Search...

Home Home  >  Financial Reports  >  Annual Reports

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
2024
2024 Cover Image
  • 2025 Proxy Statement of 2024, PDF file, (opens in new window)
  • 2024 Annual Report of 2024, PDF file, (opens in new window)
2023
2023 Cover Image
  • 2024 Proxy Statement of 2023, PDF file, (opens in new window)
  • 2023 Annual Report of 2023, PDF file, (opens in new window)
2021
2021 Cover Image
  • 2023 Proxy Statement of 2021, PDF file, (opens in new window)
  • 2022 Annual Report of 2021, PDF file, (opens in new window)
2020
2020 Cover Image
  • 2022 Proxy Statement of 2020, PDF file, (opens in new window)
  • 2021 Annual Report of 2020, PDF file, (opens in new window)
2019
2019 Cover Image
  • 2021 Proxy Statement of 2019, PDF file, (opens in new window)
  • 2020 Annual Report of 2019, PDF file, (opens in new window)
2018
2018 Cover Image
  • 2020 Proxy Statement of 2018, PDF file, (opens in new window)
  • 2019 Annual Report of 2018, PDF file, (opens in new window)
2017
2017 Cover Image
  • 2019 Proxy Statement of 2017, PDF file, (opens in new window)
  • 2018 Annual Report of 2017, PDF file, (opens in new window)
Amneal
  • About Us
    • Overview
    • Leadership
    • Global presence
      • Overview
      • United States
      • India
      • Ireland
    • Responsibility
  • Innovating Access
    • Overview
    • Timeline
    • Pipeline
    • Support
  • Essential Medicines
    • Overview
    • Biosciences
    • Specialty
    • Generics
    • Drug Safety
    • Quality
  • Connect
    • Linkedin
    • X
    • Facebook
    • Youtube
© Amneal Pharmaceuticals LLC.
All rights reserved.
  • Expandend Access Policy
  • Copyright & Legal Disclaimer
  • Privacy Notice
  • Web Accessibility
  • NABP DDA
Back to top